Vlaams Instituut Voor Biotechnologie - Flanders Institute For Biotechnology
Gent, Vlaams Gewest Doing business as VIB Vlaams Instituut Voor Biotechnologie - Vibvzw
Company facts
- Self-certified in SAM.gov
- Entity structure
- Other
- SAM.gov registration date
- Physical address
- Suzanne Tassierstraat 1, 9052 Gent, Belgium
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
Grant subawards
| Prime recipient | Prime award | Amount | Awarded |
|---|---|---|---|
| Board Of Regents Of Nevada System Of Higher Education | R01EY032101 | $330,374 | |
| Mayo Clinic | U19AG063911 | $246,024 | |
| Mayo Clinic | U19AG063911 | $101,216 |
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Fundacio De Recerca Clinic Barcelona-Institut D’investigacions Biomediques August Pi I Sunyer | Barcelona, CT | 813212 Voluntary Health Organizations |
| Institut Pasteur De Lille | Lille, Hauts-de-France | — |
| Delegation Regionale Paris-Idf Centre Nord | Paris, IDF | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Fundacio Institut De Recerca Biomedica (Irb Barcelona) | Barcelona, CT | — |
| Centre De Recherche De L'hopital Douglas | Montréal, QC | — |
About the company
Vlaams Instituut Voor Biotechnologie (VIB) is a non-profit biomedical research institute located in Gent, Belgium, focused on cutting-edge life sciences and biotechnology research. Registered in SAM.gov since 2009, VIB is a foreign-owned organization that provides advanced scientific research services to multiple U.S. federal agencies through competitive grant awards. The institute specializes in comprehensive biomedical research across multiple disciplines, with a particular emphasis on neurodegenerative diseases, cancer research, and innovative molecular biology techniques.
VIB has secured multiple significant federal grant awards from agencies including the National Institute on Aging, National Cancer Institute, Defense Health Agency, and Medical Command, focusing predominantly on neurodegenerative disease research. The grants, ranging from $131,854 to $1,045,068, support sophisticated research projects such as mapping ductal carcinoma progression, investigating frontotemporal degeneration biomarkers, studying Alzheimer's disease genetic variants, and exploring amyloid protein interactions. VIB has also participated as a sub-awardee in larger collaborative projects like the Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) program led by Mayo Clinic. Their research methodologies include advanced proteomics approaches, genetic variant analysis, 3D imaging techniques, and developing humanized disease models, with the overarching goals of understanding disease mechanisms, identifying potential biomarkers, and developing more personalized medical interventions.
Quick answers
Is Vlaams Instituut Voor Biotechnologie - Flanders Institute For Biotechnology registered in SAM.gov?
Yes. Vlaams Instituut Voor Biotechnologie - Flanders Institute For Biotechnology's SAM.gov registration is active through February 10, 2027.
What is Vlaams Instituut Voor Biotechnologie - Flanders Institute For Biotechnology's CAGE code?
Vlaams Instituut Voor Biotechnologie - Flanders Institute For Biotechnology's CAGE code is B6778, and its Unique Entity ID (UEI) is JGFVXSHCGYL1.
What is Vlaams Instituut Voor Biotechnologie - Flanders Institute For Biotechnology's most recent federal award?
Vlaams Instituut Voor Biotechnologie - Flanders Institute For Biotechnology's most recent federal grant award is The TMEM106B-GRN-TDP43 triad: leveraging human samples and humanized models to unravel ftld-TDP disease mechanisms (R01AG084672), from National Institute on Aging (NIH), on September 30, 2024.
On GovTribe
See Vlaams Instituut Voor Biotechnologie - Flanders Institute For Biotechnology's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors